PROPERDIN DEFICIENCY, X-LINKED
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System.
|
31507604 |
2019 |
PROPERDIN DEFICIENCY, X-LINKED
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Functional and structural insight into properdin control of complement alternative pathway amplification.
|
28264884 |
2017 |
PROPERDIN DEFICIENCY, X-LINKED
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Targeted Next-Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability.
|
26350204 |
2015 |
PROPERDIN DEFICIENCY, X-LINKED
|
0.700 |
Biomarker
|
disease |
CTD_human |
Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies.
|
10909851 |
2000 |
PROPERDIN DEFICIENCY, X-LINKED
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies.
|
10909851 |
2000 |
PROPERDIN DEFICIENCY, X-LINKED
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Expression of properdin in complete and incomplete deficiency: normal in vitro synthesis by monocytes in two cases with properdin deficiency type II due to distinct mutations.
|
9710744 |
1998 |
PROPERDIN DEFICIENCY, X-LINKED
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Molecular characterization of properdin deficiency type III: dysfunction produced by a single point mutation in exon 9 of the structural gene causing a tyrosine to aspartic acid interchange.
|
8871668 |
1996 |
PROPERDIN DEFICIENCY, X-LINKED
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Molecular characterization of properdin deficiency type III: dysfunction produced by a single point mutation in exon 9 of the structural gene causing a tyrosine to aspartic acid interchange.
|
8871668 |
1996 |
PROPERDIN DEFICIENCY, X-LINKED
|
0.700 |
Biomarker
|
disease |
CTD_human |
Sequence-based analysis of properdin deficiency: identification of point mutations in two phenotypic forms of an X-linked immunodeficiency.
|
8530058 |
1995 |
PROPERDIN DEFICIENCY, X-LINKED
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Properdin deficiency disease
|
0.510 |
GeneticVariation
|
disease |
BEFREE |
A splice site mutation in exon 10 (c.1487-2A>G) was found in the properdin gene and co segregated with biochemically measured properdin deficiency.
|
16337490 |
2006 |
Properdin deficiency disease
|
0.510 |
GermlineCausalMutation
|
disease |
ORPHANET |
Molecular characterization of properdin deficiency type III: dysfunction produced by a single point mutation in exon 9 of the structural gene causing a tyrosine to aspartic acid interchange.
|
8871668 |
1996 |
Properdin deficiency disease
|
0.510 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Partial properdin deficiency.
|
6903190 |
1980 |
Malignant neoplasm of breast
|
0.310 |
Biomarker
|
disease |
BEFREE |
CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3.
|
30755730 |
2019 |
Liver carcinoma
|
0.310 |
Biomarker
|
disease |
CTD_human |
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
|
28284560 |
2017 |
Liver carcinoma
|
0.310 |
Biomarker
|
disease |
BEFREE |
YB-1 protein was quantified from IL-1β- or TNFα-stimulated rat hepatoma cells (FaO) and the localization of a YFP-YB-1-CFP fusion protein was visualized by confocal microscopy in HepG2 human hepatocellular carcinoma cells.
|
22361279 |
2012 |
Malignant neoplasm of breast
|
0.310 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Liver Cirrhosis, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
Meningococcal meningitis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies.
|
10909851 |
2000 |
Meningitis, Meningococcal, Serogroup A
|
0.300 |
Biomarker
|
disease |
CTD_human |
Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies.
|
10909851 |
2000 |
Meningitis, Meningococcal, Serogroup B
|
0.300 |
Biomarker
|
disease |
CTD_human |
Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies.
|
10909851 |
2000 |
Meningitis, Meningococcal, Serogroup C
|
0.300 |
Biomarker
|
disease |
CTD_human |
Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies.
|
10909851 |
2000 |
Meningitis, Meningococcal, Serogroup Y
|
0.300 |
Biomarker
|
disease |
CTD_human |
Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies.
|
10909851 |
2000 |
Meningitis, Meningococcal, Serogroup W-135
|
0.300 |
Biomarker
|
disease |
CTD_human |
Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies.
|
10909851 |
2000 |
Meningococcal meningitis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Sequence-based analysis of properdin deficiency: identification of point mutations in two phenotypic forms of an X-linked immunodeficiency.
|
8530058 |
1995 |